Literature DB >> 28714000

Circulating levels of angiogenesis-related growth factors in breast cancer: A study to profile proteins responsible for tubule formation.

Gemma A Barron1, Marie Goua2, Klaus W J Wahle3, Giovanna Bermano1.   

Abstract

The present study exploited a versatile in vitro endothelial cell/fibroblast co-culture cell system to investigate the association between angiogenesis and breast cancer by comparing the capacity of plasma from women with breast cancer and age-matched controls, to influence tubule formation and modulate angiogenesis in vitro, and to identify plasma circulating factors which might be responsible. Plasma from women with breast cancer (n=8) (added on day 7 after co-culture establishment) significantly increased tubule formation by 57% (P<0.01) when compared to cultures grown in culture medium lacking in vascular endothelial growth factor (VEGF) and fetal bovine serum (FBS), whereas plasma from controls (n=8) did not. Higher levels of VEGF, tumour necrosis factor-α (TNFα) and interleukin (IL)-6, but not leptin, were observed in plasma samples of the breast cancer group compared to the control group (n=20 in each group). In independent experiments, the effects of VEGF, TNFα, IL-6 and leptin were assessed and it was found that tubule formation was differentially affected whether these inflammatory cytokines or adipokines were added individually or in combination to the co-culture system. Using Proteome Profiler human angiogenesis array kits, 12 out of 55 angiogenesis-related proteins were differentially expressed in plasma from the breast cancer group compared to the control group. Pro-angiogenic proteins included: amphiregulin, artemin, coagulation factor III, fibroblast growth factor (FGF) acidic, GDNF, IL-8, macrophage inflammatory protein (MIP)-1α, platelet derived growth factor-AB/platelet derived growth factor-BB (PDGF-AB/PDGF-BB) and VEGF, whereas anti-angiogenic proteins were: angiopoietin-2, serpin F1 and serpin B5. In addition, FGF acidic was further identified as differentially expressed, with increased expression, when plasma samples from the normal and cancer groups, which induced an increase in tubule formation, were compared to one another. In conclusion, the present study identified angiogenesis-related proteins circulating in the serum of women with breast cancer that are likely to facilitate the growth and metastasis of breast cancer, in part through their influence on tubule formation, and, therefore, may be potential targets for new cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28714000     DOI: 10.3892/or.2017.5803

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  Secretome Screening Reveals Fibroblast Growth Factors as Novel Inhibitors of Viral Replication.

Authors:  Saskia D van Asten; Matthijs Raaben; Benjamin Nota; Robbert M Spaapen
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

2.  In Ovo and In Silico Evaluation of the Anti-Angiogenic Potential of Syringin.

Authors:  Charlaine A Aventurado; Junie B Billones; Ross D Vasquez; Agnes L Castillo
Journal:  Drug Des Devel Ther       Date:  2020-11-25       Impact factor: 4.162

3.  VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment.

Authors:  Maria Margarete Karsten; Maximilian Heinz Beck; Angela Rademacher; Julia Knabl; Jens-Uwe Blohmer; Julia Jückstock; Julia Caroline Radosa; Paul Jank; Brigitte Rack; Wolfgang Janni
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

4.  Staphylococcus aureus β-Toxin Exerts Anti-angiogenic Effects by Inhibiting Re-endothelialization and Neovessel Formation.

Authors:  Phuong M Tran; Sharon S Tang; Wilmara Salgado-Pabón
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

Review 5.  Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches.

Authors:  Nehad M Ayoub; Sara K Jaradat; Kamal M Al-Shami; Amer E Alkhalifa
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

6.  Peri-tumoural spatial distribution of lipid composition and tubule formation in breast cancer.

Authors:  Kwok-Shing Chan; Sai Man Cheung; Nicholas Senn; Ehab Husain; Yazan Masannat; Steven Heys; Jiabao He
Journal:  BMC Cancer       Date:  2022-03-17       Impact factor: 4.430

7.  Serum Concentration of Selected Angiogenesis-Related Molecules Differs among Molecular Subtypes, Body Mass Index and Menopausal Status in Breast Cancer Patients.

Authors:  Dimitrios Balalis; Dimitrios Tsakogiannis; Eleni Kalogera; Stefania Kokkali; Elli Tripodaki; Alexandros Ardavanis; Dimitrios Manatakis; Dionysios Dimas; Nektarios Koufopoulos; Florentia Fostira; Dimitrios Korkolis; Ioannis Misitzis; Nikolaos Vassos; Chara Spiliopoulou; Dimitrios Vlachodimitropoulos; Garyfalia Bletsa; Nikolaos Arkadopoulos
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

8.  YAP Overexpression in Breast Cancer Cells Promotes Angiogenesis through Activating YAP Signaling in Vascular Endothelial Cells.

Authors:  Yu Yan; Qiang Song; Li Yao; Liang Zhao; Hui Cai
Journal:  Anal Cell Pathol (Amst)       Date:  2022-10-03       Impact factor: 4.133

Review 9.  Development of Radiotracers for Breast Cancer-The Tumor Microenvironment as an Emerging Target.

Authors:  Amelie Heesch; Jochen Maurer; Elmar Stickeler; Mohsen Beheshti; Felix M Mottaghy; Agnieszka Morgenroth
Journal:  Cells       Date:  2020-10-21       Impact factor: 6.600

10.  Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer.

Authors:  Katarzyna M Terlikowska; Bozena Dobrzycka; Robert Terlikowski; Anna Sienkiewicz; Maciej Kinalski; Slawomir J Terlikowski
Journal:  BMC Cancer       Date:  2020-09-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.